All
Multiple Myeloma Progression Still Slowed With Reduced Tecvayli Dosing
Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.
FDA-Approved Rytelo a ‘Game Changer’ for Some Patients with MDS
Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.
Moving the Needle With Disparities in Multiple Myeloma
Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.
What I Wish Medical School Had Taught Me About Cancer
Medical school didn't teach me how to help patients find hope during tough times.
Don’t Delay Bringing Up CML Concerns, a Doctor Says
To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.
Innovation and Resilience in the Genitourinary Cancer Space
Within the genitourinary cancer space, there have been many treatment advances over the past year.
Most Patients With CML Can Continue Their Normal Lifestyle During Treatment
Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.
FDA Approves Blincyto for Adults, Children with Acute Lymphoblastic Leukemia Subtype
The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’
A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.
FDA Approves Imfinzi Plus Chemo for dMMR Endometrial Cancer
The FDA approved Imfinzi plus carboplatin and paclitaxel followed by Imfinzi alone in patients with primary advanced or recurrent dMMR endometrial cancer.
Bispecific Antibodies Get ‘Fantastic’ Responses in Pretreated Myeloma
As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.
How Do I Love Myself Right Here, Right Now After Cancer?
After having breast cancer, I worked on learning to accept and love myself.
Kate Middleton Provides Cancer Treatment Update, Kevin Jonas Receives Skin Cancer Surgery and More
From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.
Reflecting on My Two Cancer Triumphs on Father’s Day
I feel most thankful on Father's Day, especially after being told I'd never be able to have children.
Putting Quality of Life into Perspective During CML Treatment
Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.
Determining Stem Cell Transplant Eligibility, Quality of Life in Myeloma
Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.
Accepting Cancer With Grace
My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me.
FDA Approves Augtyro for Children, Adults With NTRK-Positive Solid Cancers
The Food and Drug Administration approved Augtyro for patients over the age of 12 with NTRK-positive solid tumors.
Opdivo, Reirradiation May Delay Head and Neck Cancer Progression
The immunotherapy Opvido and reirradiation resulted in a one-year progression-free survival rate of 61.7% among certain patients with head and neck cancer.
Understanding the Disease, Treatments Help Patients Navigate a CML Diagnosis
Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.
3 Questions to Ask Doctors After a CML Diagnosis
An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.
FDA Approves Retevmo for Some Adults and Children With Thyroid Cancer
The Food and Drug Administration granted a traditional approval to Retevmo for adult and pediatric patients 2 years old and older with advanced or metastatic RET fusion-positive thyroid cancer.
How I Used Meditation to Help With Cancer-Related Stress
Meditation helped me quiet my mind and adopt a positive mindset after being diagnosed with cancer.
Sharing Breast Cancer Experiences is the ‘Most Special Thing’
Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.
I'm Still Me Even Though I Have Myeloma
When I told my friends and family I have multiple myeloma, some of them didn't know what to do.
Tumor Treating Fields for Brain Metastases in Lung Cancer Boost Quality of Life With Some Trade-Offs
For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.
Drug Combos Improve Outcomes in Newly Diagnosed Myeloma
New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma, an expert explained at the Educated Patient® Multiple Myeloma Summit.
Finding Alternatives to Help With Nausea During Cancer
When my sister experienced nausea and vomiting during her Hodgkin lymphoma treatment, we tried alternatives that seemed to help.
FDA to Speed Up Review of Tagrisso for EGFR-Mutant NSCLC
The Food and Drug Administration will speed up their review and potential approval of Tagrisso for certain patients with EGFR-mutant lung cancer.
Cancer Ward Day 30
In this poem, a woman with liposarcoma writes about her feelings during a long hospital stay.